Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-19
DOI
10.1038/s41598-020-72711-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
- (2018) Mariaelena Capone et al. Journal for ImmunoTherapy of Cancer
- Biomarkers for Immune Checkpoint Inhibitors in Melanoma
- (2018) Shigehisa Kitano et al. Frontiers in Oncology
- Prognostic value of neutrophil-to-lymphocyte ratio in melanoma
- (2018) Yingguo Ding et al. MEDICINE
- Interferon gamma in cancer immunotherapy
- (2018) Ling Ni et al. Cancer Medicine
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Emerging biomarkers for cancer immunotherapy in melanoma
- (2017) Margaret L. Axelrod et al. SEMINARS IN CANCER BIOLOGY
- The untold story of IFN-γ in cancer biology
- (2016) M. Alper Kursunel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The paradoxical role of IL-10 in immunity and cancer
- (2015) Mark H. Mannino et al. CANCER LETTERS
- IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
- (2015) Z. Sun et al. CANCER RESEARCH
- Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
- (2015) Ankit Saxena et al. CYTOKINE
- High IFN-γ/IL-10 Expression Ratio and Increased Frequency of Persistent Human T-Cell Lymphotropic Virus Type 1-Infected Clones Are Associated with Human T-Cell Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis Development
- (2015) Otávio M. Espíndola et al. INTERVIROLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
- (2015) Shuai Zhao et al. PLoS One
- IFN-γ regulates survival and function of tumor-induced CD11b+Gr-1highmyeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1
- (2014) José Medina-Echeverz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The immune escape in melanoma: role of the impaired dendritic cell function
- (2014) Marco Tucci et al. Expert Review of Clinical Immunology
- Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
- (2014) Soo Kyung Jeong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Current status of interleukin-10 and regulatory T-cells in cancer
- (2013) Kristen L. Dennis et al. CURRENT OPINION IN ONCOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
- (2012) Keira H. Skolimowska et al. PLoS One
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Comparison of mRNA and Protein Measures of Cytokines following Vaccination with Human Papillomavirus-16 L1 Virus-like Particles
- (2010) F. M. Shebl et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started